雪崩
发表于 2025-3-28 16:25:36
http://reply.papertrans.cn/55/5427/542687/542687_41.png
轻浮女
发表于 2025-3-28 19:39:04
Wait List Managementited Network for Organ Sharing (UNOS). UNOS matches deceased donor kidneys to recipients, taking into account both efficiency (graft and patient survival) and equity (fair distribution). Organ allocation is a complex system, taking into account blood type, HLA matching, degree of sensitization, pedi
争议的苹果
发表于 2025-3-28 23:59:31
http://reply.papertrans.cn/55/5427/542687/542687_43.png
流浪者
发表于 2025-3-29 05:13:48
http://reply.papertrans.cn/55/5427/542687/542687_44.png
Arthr-
发表于 2025-3-29 10:25:40
http://reply.papertrans.cn/55/5427/542687/542687_45.png
mosque
发表于 2025-3-29 14:31:30
Live Donor Transplantationis, excellent allograft and donor outcomes, as well as improvement in surgical technique. Recent literature has demonstrated a trend towards an increase in live donor kidney donations over the past 5 decades (Am J Transplant 13(2):390–.98, 2013). Balancing this selfless act of donation with the clin
假设
发表于 2025-3-29 19:15:08
Extended Criteria Donors in Renal Transplantationended criteria donor” (ECD) kidneys. In this chapter, this concept is expanded so the reader has a firm understanding of the clinical characteristics of these kidneys, the implications for organ allocation in the future, and anticipated outcomes that can be expected from these kidneys. Given the hig
遗传学
发表于 2025-3-29 21:45:24
Preoperative Cardiovascular Evaluation and Managements and recipients. Although transplantation improves cardiovascular risk in the long term compared with dialysis, cardiovascular diseases in aggregate comprise the most common cause of death in patients with functioning allografts at all times after kidney transplant. Achieving clinically and cost-ef
Harbor
发表于 2025-3-29 23:53:36
http://reply.papertrans.cn/55/5427/542687/542687_49.png
单片眼镜
发表于 2025-3-30 05:59:56
Mechanisms of Immunosuppressive Drugsn is an intense perioperative treatment intended to suppress anti-donor responses and prevent acute rejection during the early postoperative period (Nashan, BioDrugs 19:39–46, 2005; Halloran, N Engl J Med 351:2715–2729, 2004). Maintenance immunosuppression is long-term therapy intended to prevent re